Investigating the spread of antibiotic-resistant bacteria in hospitals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research project aims to explore the transmission of ESBL-producing Enterobacteriaceae, a type of antibiotic-resistant bacteria, in the Basel urban region. By utilizing whole genome sequencing, the study will analyze bacterial strains and mobile genetic elements to identify transmission chains and sources of hospital-acquired infections. The findings will help determine whether hospital environments or external sources contribute more significantly to the spread of these infections. The study will include samples collected from patients at the University Hospital Basel over a 16-year period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* aged above 1 year
* proven ESBL-PE carriage from any specimens obtained by routine clinical practice out and inpatients from University Hospital Basle from January 1st until December 31st 2019

Exclusion Criteria:

* not meeting inclusion criteria

Where it's running

• University Hospital Switzerland, Division of Infecteous Disease and Hospital Epidemiology
  Basel, Switzerland Recruiting

Study contacts

• Principal investigator: Sarah Tschudin-Sutter, PD MD — Division of Infectious Disease and Hopital Epidemiology, University Hospital Basle
• Study coordinator: Sarah Tschudin-Sutter, PD MD
• Email: sarah.tschudin@usb.ch
• Phone: ++41 61 328

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pneumonia After Heart Surgery: Can AI Predict It?

  This study tests whether artificial intelligence can predict hospital-acquired pneumonia after heart surgery and whether pneumonia can indicate higher risk of future heart and lung problems.

  Recruiting Tomsk National Research Medical Center of the Russian Academy of Sciences · Tomsk · NCT07745491

• Predictors and Outcomes of Ventilated Hospital-Acquired Pneumonia

  This study looks at which factors predict outcomes for patients with ventilated hospital-acquired pneumonia to help guide care.

  Recruiting Assiut University · Asyut, Asyut Governorate · NCT07667582

• Using dexamethasone to treat severe hospital-acquired pneumonia in critically ill patients

  This study is testing if adding dexamethasone to standard treatment helps critically ill patients with severe hospital-acquired pneumonia feel better compared to those who only get standard treatment.

  Recruiting at 19 sites Phase 3 Nantes University Hospital · Amiens and 33 other locations · NCT06269900

• Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus

  This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.

  Recruiting at 28 sites Phase 3 Jena University Hospital · Freiburg im Breisgau, Baden-Wurttemberg and 27 other locations · NCT06134492

• Early treatment with targeted antibiotics for severe infections using rapid diagnostics

  This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.

  Recruiting at 21 sites Phase 4 National University of Singapore · Vellore and 20 other locations · NCT05979545

• Learning about the safety and effectiveness of Zavicefta in Korea

  This study is trying to learn how safe and effective Zavicefta is for treating serious infections in both adults and kids in Korea after it has been released for use.

  Recruiting Pfizer · Seoul, Gangnam-gu · NCT05733104

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.